Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
hypoxia-inducible factor 1 alpha subunit | 11 | 0 | 0 | 11 |
RAR-related orphan receptor gamma | 18 | 0 | 0 | 18 |
GLI family zinc finger 3 | 21 | 0 | 0 | 21 |
AR protein | 32 | 0 | 0 | 32 |
aldehyde dehydrogenase 1 family, member A1 | 11 | 0 | 0 | 11 |
retinoic acid nuclear receptor alpha variant 1 | 22 | 0 | 0 | 22 |
retinoid X nuclear receptor alpha | 18 | 0 | 0 | 18 |
estrogen nuclear receptor alpha | 35 | 0 | 0 | 35 |
peroxisome proliferator-activated receptor delta | 16 | 0 | 0 | 16 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 22 | 0 | 0 | 22 |
activating transcription factor 6 | 8 | 0 | 0 | 8 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 15 | 0 | 0 | 15 |
Histone H2A.x | 5 | 0 | 0 | 5 |
thyroid hormone receptor beta isoform a | 6 | 0 | 0 | 6 |
heat shock protein beta-1 | 10 | 0 | 0 | 10 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 19 | 0 | 0 | 19 |
lamin isoform A-delta10 | 16 | 0 | 0 | 16 |
Voltage-dependent calcium channel gamma-2 subunit | 11 | 0 | 0 | 11 |
Glutamate receptor 2 | 11 | 0 | 0 | 11 |
TDP1 protein | 18 | 0 | 0 | 18 |
glucocorticoid receptor [Homo sapiens] | 29 | 0 | 0 | 29 |
estrogen-related nuclear receptor alpha | 26 | 0 | 0 | 26 |
thyroid hormone receptor beta isoform 2 | 19 | 0 | 0 | 19 |
Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
Prostaglandin G/H synthase 2 | 0 | 5 | 0 | 5 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 10 | 0 | 0 | 10 |
aryl hydrocarbon receptor | 17 | 0 | 0 | 17 |
Spike glycoprotein | 7 | 0 | 1 | 8 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 5 | 0 | 0 | 5 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 7 | 0 | 0 | 7 |
Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
Chain A, HADH2 protein | 7 | 0 | 0 | 7 |
Chain B, HADH2 protein | 7 | 0 | 0 | 7 |
Chain A, 2-oxoglutarate Oxygenase | 6 | 0 | 0 | 6 |
GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
ras protein, partial | 0 | 0 | 1 | 1 |
interleukin 8 | 5 | 0 | 0 | 5 |
thioredoxin reductase | 7 | 0 | 0 | 7 |
GLS protein | 5 | 0 | 0 | 5 |
thyroid stimulating hormone receptor | 7 | 0 | 0 | 7 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
EWS/FLI fusion protein | 3 | 0 | 0 | 3 |
cytochrome P450 2D6 | 9 | 0 | 0 | 9 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
Rac1 protein | 0 | 0 | 1 | 1 |
IDH1 | 8 | 0 | 0 | 8 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 12 | 0 | 0 | 12 |
Bloom syndrome protein isoform 1 | 3 | 0 | 0 | 3 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 5 | 0 | 0 | 5 |
DNA polymerase iota isoform a (long) | 8 | 0 | 0 | 8 |
DNA polymerase kappa isoform 1 | 7 | 0 | 0 | 7 |
muscarinic acetylcholine receptor M1 | 4 | 0 | 0 | 4 |
lethal factor (plasmid) | 5 | 0 | 0 | 5 |
Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 8 | 0 | 8 |
Multidrug resistance-associated protein 4 | 0 | 8 | 0 | 8 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Bile salt export pump | 0 | 13 | 0 | 13 |
Epidermal growth factor receptor | 0 | 5 | 0 | 5 |
Carbonic anhydrase 1 | 0 | 9 | 0 | 9 |
Carbonic anhydrase 2 | 0 | 9 | 0 | 9 |
Fatty acid-binding protein, liver | 0 | 3 | 0 | 3 |
Integrin beta-3 | 1 | 1 | 0 | 2 |
Myeloperoxidase | 0 | 1 | 0 | 1 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 2 | 0 | 2 |
Integrin alpha-IIb | 1 | 1 | 0 | 2 |
Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
Adenosine receptor A1 | 0 | 5 | 0 | 5 |
Adenosine receptor A2a | 0 | 4 | 0 | 4 |
Substance-P receptor | 0 | 2 | 0 | 2 |
Urotensin-2 receptor | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 2 | 0 | 2 |
Nuclear receptor ROR-gamma | 4 | 0 | 0 | 4 |
Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 7 | 1 | 0 | 8 |
Prostaglandin G/H synthase 2 | 0 | 4 | 0 | 4 |
Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 8 | 0 | 8 |
Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
glp-1 receptor, partial | 4 | 0 | 0 | 4 |
ATAD5 protein, partial | 7 | 0 | 0 | 7 |
USP1 protein, partial | 11 | 0 | 0 | 11 |
nuclear receptor subfamily 1, group I, member 3 | 8 | 0 | 0 | 8 |
G | 6 | 0 | 0 | 6 |
thyroid stimulating hormone receptor | 8 | 0 | 0 | 8 |
nuclear receptor ROR-gamma isoform 1 | 6 | 0 | 0 | 6 |
geminin | 16 | 0 | 0 | 16 |
cytochrome P450 3A4 isoform 1 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit pi | 7 | 0 | 0 | 7 |
Interferon beta | 9 | 0 | 0 | 9 |
HLA class I histocompatibility antigen, B alpha chain | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit beta-1 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit delta | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit beta-3 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit beta-2 | 7 | 0 | 0 | 7 |
TAR DNA-binding protein 43 | 7 | 0 | 0 | 7 |
GABA theta subunit | 7 | 0 | 0 | 7 |
Inositol hexakisphosphate kinase 1 | 6 | 0 | 0 | 6 |
ATPase family AAA domain-containing protein 5 | 11 | 0 | 0 | 11 |
Ataxin-2 | 13 | 0 | 0 | 13 |
Gamma-aminobutyric acid receptor subunit epsilon | 7 | 0 | 0 | 7 |
cytochrome P450 2C9, partial | 6 | 0 | 0 | 6 |
pregnane X receptor | 4 | 0 | 0 | 4 |
progesterone receptor | 17 | 0 | 0 | 17 |
farnesoid X nuclear receptor | 10 | 0 | 0 | 10 |
pregnane X nuclear receptor | 19 | 0 | 0 | 19 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 13 | 0 | 0 | 13 |
nuclear receptor subfamily 1, group I, member 2 | 8 | 0 | 0 | 8 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 8 | 0 | 0 | 8 |
galanin receptor type 3 | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 18 | 2 | 25 |
Glycine receptor subunit alpha-1 | 0 | 18 | 0 | 18 |
Glycine receptor subunit beta | 0 | 18 | 0 | 18 |
Glycine receptor subunit alpha-2 | 0 | 18 | 0 | 18 |
Glycine receptor subunit alpha-3 | 0 | 18 | 0 | 18 |
ORF73 | 0 | 0 | 2 | 2 |
SMAD family member 2 | 10 | 0 | 0 | 10 |
SMAD family member 3 | 10 | 0 | 0 | 10 |
peroxisome proliferator activated receptor gamma | 17 | 0 | 0 | 17 |
Chain A, Beta-lactamase | 6 | 0 | 0 | 6 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 2 | 0 | 0 | 2 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
Chain A, Neutrophil gelatinase-associated lipocalin | 0 | 0 | 1 | 1 |
endonuclease IV | 4 | 0 | 0 | 4 |
Nrf2 | 1 | 0 | 0 | 1 |
15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
NFKB1 protein, partial | 4 | 0 | 0 | 4 |
Microtubule-associated protein tau | 3 | 0 | 0 | 3 |
Thrombopoietin | 2 | 0 | 0 | 2 |
thioredoxin glutathione reductase | 4 | 0 | 0 | 4 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 9 | 0 | 0 | 9 |
estrogen receptor 2 (ER beta) | 6 | 0 | 0 | 6 |
regulator of G-protein signaling 4 | 4 | 0 | 0 | 4 |
Parkin | 1 | 0 | 0 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 8 | 0 | 0 | 8 |
NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 5 | 0 | 0 | 5 |
chromobox protein homolog 1 | 9 | 0 | 0 | 9 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
DNA polymerase beta | 1 | 0 | 0 | 1 |
flap endonuclease 1 | 2 | 0 | 0 | 2 |
ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 4 | 0 | 0 | 4 |
plasminogen precursor | 4 | 0 | 0 | 4 |
urokinase plasminogen activator surface receptor precursor | 4 | 0 | 0 | 4 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
survival motor neuron protein isoform d | 5 | 0 | 0 | 5 |
M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 2 | 0 | 2 |
Cellular tumor antigen p53 | 17 | 0 | 0 | 17 |
Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
3-dehydroquinate synthase | 0 | 1 | 0 | 2 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
Potassium-transporting ATPase subunit beta | 0 | 0 | 0 | 1 |
Potassium-transporting ATPase alpha chain 1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 5 | 0 | 5 |
Carbonic anhydrase 6 | 0 | 5 | 0 | 5 |
Carbonic anhydrase 5A, mitochondrial | 0 | 3 | 0 | 3 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 3 | 0 | 3 |
Histamine H2 receptor | 2 | 0 | 0 | 3 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
Autoinducer 2-binding periplasmic protein LuxP | 0 | 1 | 0 | 1 |
E3 ubiquitin-protein ligase Mdm2 | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 3 | 0 | 3 |
Arginase-1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase 3 | 0 | 4 | 0 | 4 |
Carbonic anhydrase 15 | 0 | 4 | 0 | 4 |
Carbonic anhydrase 13 | 0 | 3 | 0 | 3 |
Carbonic anhydrase 14 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 5B, mitochondrial | 0 | 3 | 0 | 3 |
phosphoglycerate kinase | 1 | 0 | 0 | 1 |
ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
acetylcholinesterase | 6 | 0 | 0 | 6 |
caspase 7, apoptosis-related cysteine protease | 4 | 0 | 0 | 4 |
67.9K protein | 3 | 0 | 0 | 3 |
caspase-3 | 4 | 0 | 0 | 4 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 6 | 0 | 0 | 6 |
mitogen-activated protein kinase 1 | 5 | 0 | 0 | 5 |
Caspase-2 | 0 | 0 | 1 | 1 |
Inositol monophosphatase 1 | 3 | 0 | 0 | 3 |
peripheral myelin protein 22 | 3 | 0 | 0 | 3 |
Carbonic anhydrase | 0 | 3 | 0 | 3 |
Smad3 | 5 | 0 | 0 | 5 |
Snq2p | 0 | 0 | 0 | 1 |
importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
snurportin-1 | 2 | 0 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
D(1A) dopamine receptor | 0 | 1 | 0 | 1 |
D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
Histamine H1 receptor | 0 | 7 | 0 | 7 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 2 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 2 | 0 | 2 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
Protein-arginine deiminase type-4 | 0 | 2 | 0 | 2 |
dopamine D1 receptor | 2 | 0 | 0 | 2 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
Sex hormone-binding globulin | 0 | 0 | 2 | 2 |
Corticosteroid-binding globulin | 0 | 3 | 0 | 3 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
Beta-glucuronidase | 0 | 1 | 0 | 1 |
Beta-glucuronidase | 0 | 1 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 3 | 0 | 3 |
Alpha-synuclein | 2 | 1 | 0 | 3 |
G-protein coupled bile acid receptor 1 | 0 | 0 | 1 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
NPC1-like intracellular cholesterol transporter 1 | 0 | 0 | 1 | 1 |
Vascular endothelial growth factor receptor 2 | 0 | 1 | 0 | 1 |
Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
Histone acetyltransferase p300 | 0 | 1 | 0 | 1 |
CREB-binding protein | 0 | 1 | 0 | 1 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
Vpr | 1 | 0 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
histone deacetylase 9 isoform 3 | 2 | 0 | 0 | 2 |
potassium voltage-gated channel subfamily H member 2 isoform d | 3 | 0 | 0 | 3 |
Luciferase | 8 | 0 | 0 | 8 |
phosphopantetheinyl transferase | 2 | 0 | 0 | 2 |
cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
huntingtin isoform 2 | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
Cytochrome P450 2C9 | 0 | 5 | 0 | 5 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
Histamine H1 receptor | 0 | 0 | 1 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
Histamine N-methyltransferase | 0 | 0 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 4 | 0 | 4 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 3 | 0 | 3 |
Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
Calcium release-activated calcium channel protein 1 | 0 | 1 | 0 | 1 |
Protein orai-2 | 0 | 1 | 0 | 1 |
Protein orai-3 | 0 | 1 | 0 | 1 |
Histamine H4 receptor | 0 | 2 | 0 | 2 |
Histamine H3 receptor | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Replicase polyprotein 1a | 0 | 1 | 1 | 2 |
Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
Nuclear factor NF-kappa-B p105 subunit | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 3 | 0 | 3 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Beta-secretase 1 | 0 | 1 | 0 | 1 |
GALC protein | 1 | 0 | 0 | 1 |
Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E | 0 | 0 | 1 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain A, Cruzipain | 2 | 0 | 0 | 2 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
Spike glycoprotein | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
Procathepsin L | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
nonstructural protein 1 | 2 | 0 | 0 | 2 |
arylsulfatase A | 3 | 0 | 0 | 3 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
muscleblind-like protein 1 isoform 1 | 3 | 0 | 0 | 3 |
Acid-sensing ion channel 3 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 1 |
Bile salt export pump | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Albumin | 0 | 1 | 1 | 2 |
Albumin | 0 | 1 | 0 | 1 |
Albumin | 0 | 0 | 1 | 1 |
Cholinesterase | 0 | 2 | 0 | 2 |
Fatty acid-binding protein, intestinal | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 2B7 | 0 | 0 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Caspase-1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
Aldo-keto reductase family 1 member C3 | 0 | 2 | 0 | 2 |
Caspase-3 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
Caspase-4 | 0 | 1 | 0 | 1 |
Caspase-5 | 0 | 1 | 0 | 1 |
Caspase-9 | 0 | 1 | 0 | 1 |
Acid-sensing ion channel 1 | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
Dihydroorotate dehydrogenase | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Genome polyprotein | 0 | 1 | 0 | 1 |
Protease | 0 | 1 | 0 | 1 |
Integrase | 0 | 1 | 0 | 1 |
Histone-lysine N-methyltransferase SETD7 | 0 | 1 | 0 | 1 |
Cysteine protease | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 22 | 0 | 1 | 0 | 1 |
P2X purinoceptor 7 | 0 | 1 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 3 | 0 | 0 | 3 |
Free fatty acid receptor 1 | 0 | 0 | 1 | 1 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Trypsin | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, heart | 0 | 2 | 0 | 2 |
Coagulation factor VII | 0 | 1 | 0 | 1 |
Aromatase | 0 | 1 | 0 | 1 |
Tissue factor | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, adipocyte | 0 | 2 | 0 | 2 |
Tyrosine-protein phosphatase non-receptor type 7 | 0 | 1 | 0 | 1 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Dual specificity protein phosphatase 3 | 0 | 1 | 0 | 1 |
Fatty acid-binding protein 5 | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor alpha | 2 | 0 | 0 | 2 |
Free fatty acid receptor 4 | 0 | 0 | 1 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Secreted chorismate mutase | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily M member 8 | 0 | 1 | 2 | 4 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Transient receptor potential cation channel subfamily M member 8 | 0 | 0 | 1 | 1 |
PPM1D protein | 2 | 0 | 0 | 2 |
bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
Androgen receptor | 0 | 3 | 0 | 3 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Histone deacetylase 3 | 0 | 2 | 0 | 2 |
Nuclear receptor corepressor 1 | 0 | 1 | 0 | 1 |
Integrin beta-1 | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 3 | 1 | 4 |
Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
Integrin alpha-4 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
Histone deacetylase 4 | 0 | 1 | 0 | 1 |
Histone deacetylase 1 | 0 | 2 | 0 | 2 |
Histone deacetylase 7 | 0 | 1 | 0 | 1 |
Histone deacetylase 2 | 0 | 2 | 0 | 2 |
Histone deacetylase 11 | 0 | 1 | 0 | 1 |
Histone deacetylase 8 | 0 | 1 | 0 | 1 |
Histone deacetylase 6 | 0 | 1 | 0 | 1 |
Histone deacetylase 5 | 0 | 1 | 0 | 1 |
Nuclear receptor corepressor 2 | 0 | 1 | 0 | 1 |
Sodium/iodide cotransporter | 0 | 1 | 0 | 1 |
vasopressin V1b receptor | 1 | 0 | 0 | 1 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Tumor necrosis factor | 0 | 1 | 0 | 1 |
Adenosine receptor A2b | 0 | 1 | 0 | 1 |
Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Chitotriosidase-1 | 0 | 2 | 1 | 3 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
Endochitinase B1 | 0 | 2 | 1 | 3 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Lysozyme | 0 | 0 | 1 | 1 |
Chain A, Lysozyme | 0 | 0 | 1 | 1 |
Chain A, Lysozyme | 0 | 0 | 1 | 1 |
Chain A, Lysozyme | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
alpha-galactosidase | 2 | 0 | 0 | 2 |
Polyphenol oxidase 2 | 0 | 0 | 0 | 1 |
Endolysin | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 0 | 1 | 1 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 0 | 1 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
luciferase | 0 | 0 | 0 | 1 |
Estrogen receptor | 0 | 2 | 0 | 2 |
Progesterone receptor | 0 | 2 | 0 | 3 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
Androgen receptor | 0 | 2 | 0 | 2 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 2 | 0 | 2 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, 146aa long hypothetical transcriptional regulator | 0 | 0 | 1 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain B, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain C, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
Cytochrome P450 3A5 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 2 | 1 | 3 |
Peptidyl-prolyl cis-trans isomerase FKBP1B | 0 | 0 | 1 | 1 |
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP5 | 0 | 1 | 0 | 1 |
Splicing factor 3B subunit 3 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B1 | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Thymidine kinase, cytosolic | 0 | 2 | 0 | 4 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Thymidylate synthase | 0 | 0 | 0 | 1 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 0 | 0 | 2 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Thymidine kinase | 0 | 0 | 0 | 1 |
procathepsin L isoform 1 preproprotein | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 2 | 0 | 2 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |